webinar register page

Webinar banner
Scientific Collaboration Using Innovative Remote Technologies
When COVID-19 started to spread across continents and become a global pandemic, biopharma manufacturers around the world faced two major challenges: (1) enter the race for treatment of the disease by participating in vaccine development and (2) avoid delays in the production of other essential therapeutics. This video webinar presents two case studies from Europe and Latin America that demonstrate how the global teams across the M Lab™ Collaboration Center network used innovative remote technologies to overcome these challenges and meet important production timelines.

You will explore:

• A remote collaboration in Europe where the team remotely supported process development, scale up and scale out of a COVID-19 vaccine candidate.

• A case study in Latin America where the team used remote technologies to show a customer how to concentrate and diafiltrate their antivenom serum production in Peru.

• A virtual experience of how remote technologies are used to promote scientific collaboration.

Dec 16, 2020 11:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Michael Burns
Senior Engineer @MilliporeSigma
Michael Burns is a Senior Engineer within the Manufacturing and Sciences Technology (MSAT) team at MilliporeSigma and is based in Northern Ireland. He obtained a BSc (Hons) degree in Industrial Biotechnology at South Bank University in London, after which he completed an MSc (Eng) in Biochemical Engineering and then a PhD in Chemical Engineering at the University of Birmingham in the UK. He has held senior positions in both process science and production management at Avecia Biologics (now Fujifilm Diosynth) and at Ipsen Biopharm. He was part of the team which successfully obtained FDA approval for Ipsen’s botulinum toxin product for both therapeutic and cosmetic use in the US and has interacted with many international regulatory agencies. Michael has been working for MilliporeSigma for four years, during which time he has collaborated with many international customers on projects involving process design, trouble shooting, optimization and scale-up.
Josselyn Haas Durr
Senior Manager @MilliporeSigma
Josselyn Haas Durr is a Senior Manager within the Manufacturing Sciences and technology (MSAT) team. His team’s main activities include the development of biopharmaceutical processes, process optimization, implementation, scale up and troubleshooting, focusing mainly on the clinical and commercial scale areas for all downstream applications. Josselyn also carries out investigations on process deviations. He joined MilliporeSigma in 2006 and has held different pharma downstream processing expert positions. Josselyn holds a Master Degree in Biotechnology Engineering from the “Ecole Nationale Supérieure de Technologie des Biomolecules” (ENSTBB) de Bordeaux (France).
Victor Gabriel Abramant de Sousa, B.Sc.
Process Development Scientist @MilliporeSigma
Victor graduated in Biology at Centro Univesitário São Camilo. He has been working as a process development scientist for 7 years, offering practical tests and technical-scientific support for downstream steps such as clarification, sterilizing filtration, virus removal, chromatography and tangential flow filtration systems focused on the industrial area. In this period, Victor was responsible for the development and scale up of several stages of production processes of vaccines, antibodies and recombinant proteins, involving multiple companies in the areas of human and animal health.